tedisamil has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrovic, V; Oehm, E; Pitschner, HF; Schlepper, M; Strasser, R | 1 |
| Abraham, S; Beatch, GN; MacLeod, BA; Walker, MJ; Yoshida, NR | 1 |
1 trial(s) available for tedisamil and Myocardial Infarction
| Article | Year |
|---|---|
[The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease].
Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Catheterization; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Potassium Channels | 1996 |
1 other study(ies) available for tedisamil and Myocardial Infarction
| Article | Year |
|---|---|
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arterial Occlusive Diseases; Blood Pressure; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Heart; Heart Rate; Male; Myocardial Infarction; Potassium Channels; Rats; Rats, Inbred Strains; Refractory Period, Electrophysiological; Ventricular Fibrillation | 1991 |